(Q34606256)

English

The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2009 on the treatment of acute mania

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

3 August 2017

The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2009 on the treatment of acute mania (English)

1 reference

Europe PubMed Central

3 August 2017

0 references

biological psychiatry

1 reference

based on heuristic

inferred from title

Siegfried Kasper

7

object named as

Siegfried Kasper

0 references

object named as

Heinz Grunze

1

0 references

object named as

Eduard Vieta

2

0 references

Hans-Jürgen Möller

6

object named as

Hans-Jurgen Moller

1 reference

Europe PubMed Central

3 August 2017

3

object named as

Guy M Goodwin

1 reference

Europe PubMed Central

3 August 2017

5

object named as

Rasmus W Licht

1 reference

Europe PubMed Central

3 August 2017

author name string

Charles Bowden

4

1 reference

Europe PubMed Central

3 August 2017

publication date

1 January 2009

1 reference

Europe PubMed Central

3 August 2017

World Journal of Biological Psychiatry

1 reference

Europe PubMed Central

3 August 2017

10

1 reference

Europe PubMed Central

3 August 2017

2

1 reference

Europe PubMed Central

3 August 2017

85-116

1 reference

Europe PubMed Central

3 August 2017

Metabolic dysregulation with atypical antipsychotics occurs in the absence of underlying disease: a placebo-controlled study of olanzapine and risperidone in dogs

1 reference

https://api.crossref.org/works/10.1080%2F15622970902823202

21 January 2018

Linear relationship of valproate serum concentration to response and optimal serum levels for acute mania

1 reference

https://api.crossref.org/works/10.1080%2F15622970902823202

21 January 2018

Zotepine loading in acute and severely manic patients: a pilot study

1 reference

https://api.crossref.org/works/10.1080%2F15622970902823202

21 January 2018

Do many patients with depression suffer from bipolar disorder?

1 reference

https://api.crossref.org/works/10.1080%2F15622970902823202

21 January 2018

Clozapine treatment of euphoric mania.

1 reference

https://api.crossref.org/works/10.1080%2F15622970902823202

21 January 2018

The role of gender in mixed mania

1 reference

https://api.crossref.org/works/10.1080%2F15622970902823202

21 January 2018

Acute dysphoric mania: treatment response to olanzapine versus placebo

1 reference

https://api.crossref.org/works/10.1080%2F15622970902823202

21 January 2018

Efficacy of olanzapine combined with valproate or lithium in the treatment of dysphoric mania

1 reference

https://api.crossref.org/works/10.1080%2F15622970902823202

21 January 2018

World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and post-traumatic stress disorders - first revision

1 reference

https://api.crossref.org/works/10.1080%2F15622970902823202

21 January 2018

Bifrontal versus bitemporal electroconvulsive therapy in severe manic patients.

1 reference

https://api.crossref.org/works/10.1080%2F15622970902823202

21 January 2018

The AGNP-TDM expert group consensus guidelines: therapeutic drug monitoring in psychiatry

1 reference

https://api.crossref.org/works/10.1080%2F15622970902823202

21 January 2018

Bipolar II disorder : epidemiology, diagnosis and management

1 reference

https://api.crossref.org/works/10.1080%2F15622970902823202

21 January 2018

Clonazepam in acute mania: time-blind evaluation of clinical response and concentrations in plasma

1 reference

https://api.crossref.org/works/10.1080%2F15622970902823202

21 January 2018

A 12-week, open, randomized trial comparing sodium valproate to lithium in patients with bipolar I disorder suffering from a manic episode

1 reference

https://api.crossref.org/works/10.1080%2F15622970902823202

21 January 2018

Valproate in bipolar disorder: 2000 onwards

1 reference

https://api.crossref.org/works/10.1080%2F15622970902823202

21 January 2018

A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression

1 reference

https://api.crossref.org/works/10.1080%2F15622970902823202

21 January 2018

Cerebellar volume and long-term use of phenytoin

1 reference

https://api.crossref.org/works/10.1080%2F15622970902823202

21 January 2018

A double-blind, randomized, placebo-controlled study of quetiapine as adjunctive treatment for adolescent mania

1 reference

https://api.crossref.org/works/10.1080%2F15622970902823202

21 January 2018

Calcium antagonists in mania: a double-blind study of verapamil.

1 reference

https://api.crossref.org/works/10.1080%2F15622970902823202

21 January 2018

A diagnostic interview: the schedule for affective disorders and schizophrenia

1 reference

https://api.crossref.org/works/10.1080%2F15622970902823202

21 January 2018

Treatment guidelines for bipolar disorder: a critical review.

1 reference

https://api.crossref.org/works/10.1080%2F15622970902823202

21 January 2018

A double-blind comparison of valproate and lithium in the treatment of acute mania

1 reference

https://api.crossref.org/works/10.1080%2F15622970902823202

21 January 2018

Clozapine in bipolar disorder: treatment implications for other atypical antipsychotics

1 reference

https://api.crossref.org/works/10.1080%2F15622970902823202

21 January 2018

Antiepileptic drugs in mood-disordered patients

1 reference

https://api.crossref.org/works/10.1080%2F15622970902823202

21 January 2018

Atypical antipsychotics in the treatment of schizophrenia: systematic overview and meta-regression analysis

1 reference

https://api.crossref.org/works/10.1080%2F15622970902823202

21 January 2018

Pharmacological Treatment Patterns at Study Entry for the First 500 STEP-BD Participants.

1 reference

https://api.crossref.org/works/10.1080%2F15622970902823202

21 January 2018

Levetiracetam for acute mania

1 reference

https://api.crossref.org/works/10.1080%2F15622970902823202

21 January 2018

Lamotrigine: a review of its use in bipolar disorder

1 reference

https://api.crossref.org/works/10.1080%2F15622970902823202

21 January 2018

Recurrence of mania after lithium withdrawal. Implications for the use of lithium in the treatment of bipolar affective disorder.

1 reference

https://api.crossref.org/works/10.1080%2F15622970902823202

21 January 2018

ECNP consensus meeting. Bipolar depression. Nice, March 2007.

1 reference

https://api.crossref.org/works/10.1080%2F15622970902823202

21 January 2018

Clozapine in the treatment of refractory psychotic mania

1 reference

https://api.crossref.org/works/10.1080%2F15622970902823202

21 January 2018

Ziprasidone for schizophrenia and bipolar disorder: a review of the clinical trials.

1 reference

https://api.crossref.org/works/10.1080%2F15622970902823202

21 January 2018

Lithium in the acute treatment of bipolar disorders-a stocktaking

1 reference

https://api.crossref.org/works/10.1080%2F15622970902823202

21 January 2018

Relevance of new and newly rediscovered anticonvulsants for atypical forms of bipolar disorder

1 reference

https://api.crossref.org/works/10.1080%2F15622970902823202

21 January 2018

World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of bipolar disorders. Part I: Treatment of bipolar depression

1 reference

https://api.crossref.org/works/10.1080%2F15622970902823202

21 January 2018

The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders, Part II: Treatment of Mania

1 reference

https://api.crossref.org/works/10.1080%2F15622970902823202

21 January 2018

The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders, part III: maintenance treatment

1 reference

https://api.crossref.org/works/10.1080%2F15622970902823202

21 January 2018

Psychological treatment for bipolar disorders--a review of randomised controlled trials.

1 reference

https://api.crossref.org/works/10.1080%2F15622970902823202

21 January 2018

Why olanzapine beats risperidone, risperidone beats quetiapine, and quetiapine beats olanzapine: an exploratory analysis of head-to-head comparison studies of second-generation antipsychotics

1 reference

https://api.crossref.org/works/10.1080%2F15622970902823202

21 January 2018

Double-blind randomized controlled study comparing short-term efficacy of bifrontal and bitemporal electroconvulsive therapy in acute mania.

1 reference

https://api.crossref.org/works/10.1080%2F15622970902823202

21 January 2018

A review of the evidence for carbamazepine and oxcarbazepine in the treatment of bipolar disorder

1 reference

https://api.crossref.org/works/10.1080%2F15622970902823202

21 January 2018

Rapid antimanic effect of risperidone monotherapy: a 3-week multicenter, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1080%2F15622970902823202

21 January 2018

Verapamil for the treatment of acute mania: a double-blind, placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1080%2F15622970902823202

21 January 2018

The Northwick Park "functional" psychosis study: diagnosis and treatment response.

1 reference

https://api.crossref.org/works/10.1080%2F15622970902823202

21 January 2018

The first open study of zonisamide, a novel anticonvulsant, shows efficacy in mania.

1 reference

https://api.crossref.org/works/10.1080%2F15622970902823202

21 January 2018

Right prefrontal TMS versus sham treatment of mania: a controlled study

1 reference

https://api.crossref.org/works/10.1080%2F15622970902823202

21 January 2018

Delirious mania: clinical features and treatment response

1 reference

https://api.crossref.org/works/10.1080%2F15622970902823202

21 January 2018

Tardive Dyskinesia: analysis of outpatients with schizophrenia from Africa and the Middle East, Asia, Central and Eastern Europe, and Latin America

1 reference

https://api.crossref.org/works/10.1080%2F15622970902823202

21 January 2018

A pilot study of rapid lithium administration in the treatment of acute mania

1 reference

https://api.crossref.org/works/10.1080%2F15622970902823202

21 January 2018

Relationship between serum valproate and lithium levels and efficacy and tolerability in bipolar maintenance therapy.

1 reference

https://api.crossref.org/works/10.1080%2F15622970902823202

21 January 2018

A placebo-controlled, double-blind study of the efficacy and safety of aripiprazole in patients with acute bipolar mania

1 reference

https://api.crossref.org/works/10.1080%2F15622970902823202

21 January 2018

Ziprasidone in the treatment of acute bipolar mania: a three-week, placebo-controlled, double-blind, randomized trial

1 reference

https://api.crossref.org/works/10.1080%2F15622970902823202

21 January 2018

Risperidone in the treatment of acute mania: double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1080%2F15622970902823202

21 January 2018

Importance of Psychiatric Diagnosis in Prediction of Clinical Drug Effects

1 reference

https://api.crossref.org/works/10.1080%2F15622970902823202

21 January 2018

A pilot study of hormone modulation as a new treatment for mania in women with bipolar affective disorder

1 reference

https://api.crossref.org/works/10.1080%2F15622970902823202

21 January 2018

Comparison of rapid-cycling and non-rapid-cycling bipolar disorder based on prospective mood ratings in 539 outpatients.

1 reference

https://api.crossref.org/works/10.1080%2F15622970902823202

21 January 2018

Topiramate monotherapy in the management of acute mania: results of four double-blind placebo-controlled trials

1 reference

https://api.crossref.org/works/10.1080%2F15622970902823202

21 January 2018

Typical neuroleptics vs. atypical antipsychotics in the treatment of acute mania in a natural setting

1 reference

https://api.crossref.org/works/10.1080%2F15622970902823202

21 January 2018

Commercial influence and the content of medical journals

1 reference

https://api.crossref.org/works/10.1080%2F15622970902823202

21 January 2018

Pharmaceutical industry sponsorship and research outcome and quality: systematic review

1 reference

https://api.crossref.org/works/10.1080%2F15622970902823202

21 January 2018

Effectiveness of antipsychotic drugs in patients with chronic schizophrenia

1 reference

https://api.crossref.org/works/10.1080%2F15622970902823202

21 January 2018

Region-selective reduction of brain serotonin turnover rate and serotonin agonist-induced behavior in mice treated with clonazepam

1 reference

https://api.crossref.org/works/10.1080%2F15622970902823202

21 January 2018

Polytherapy in bipolar disorder

1 reference

https://api.crossref.org/works/10.1080%2F15622970902823202

21 January 2018

Olanzapine: a review of its use in the management of bipolar I disorder

1 reference

https://api.crossref.org/works/10.1080%2F15622970902823202

21 January 2018

Lithium revisited.

1 reference

https://api.crossref.org/works/10.1080%2F15622970902823202

21 January 2018

Quetiapine or haloperidol as monotherapy for bipolar mania--a 12-week, double-blind, randomised, parallel-group, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1080%2F15622970902823202

21 January 2018

Aripiprazole: pharmacology and evidence in bipolar disorder

1 reference

https://api.crossref.org/works/10.1080%2F15622970902823202

21 January 2018

A double-blind, randomized comparison of the efficacy and safety of intramuscular injections of olanzapine, lorazepam, or placebo in treating acutely agitated patients diagnosed with bipolar mania

1 reference

https://api.crossref.org/works/10.1080%2F15622970902823202

21 January 2018

Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication

1 reference

https://api.crossref.org/works/10.1080%2F15622970902823202

21 January 2018

Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register

1 reference

https://api.crossref.org/works/10.1080%2F15622970902823202

21 January 2018

Olanzapine versus lithium in the acute treatment of bipolar mania: a double-blind, randomized, controlled trial.

1 reference

https://api.crossref.org/works/10.1080%2F15622970902823202

21 January 2018

Comparison of the antimanic efficacy of carbamazepine and chlorpromazine: A double-blind controlled study

1 reference

https://api.crossref.org/works/10.1080%2F15622970902823202

21 January 2018

Comparison of the antimanic efficacy of carbamazepine and lithium carbonate by double-blind controlled study.

1 reference

https://api.crossref.org/works/10.1080%2F15622970902823202

21 January 2018

Rapid dose titration of quetiapine for the treatment of acute schizophrenia and acute mania: a case series

1 reference

https://api.crossref.org/works/10.1080%2F15622970902823202

21 January 2018

Gabapentin in bipolar disorder: a placebo-controlled trial of adjunctive therapy. Gabapentin Bipolar Disorder Study Group

1 reference

https://api.crossref.org/works/10.1080%2F15622970902823202

21 January 2018

Use of treatment guidelines in clinical decision making in bipolar disorder: a pilot survey of clinicians

1 reference

https://api.crossref.org/works/10.1080%2F15622970902823202

21 January 2018

Industry sponsorship and financial conflict of interest in the reporting of clinical trials in psychiatry

1 reference

https://api.crossref.org/works/10.1080%2F15622970902823202

21 January 2018

Valproate in the treatment of acute mania. A placebo-controlled study

1 reference

https://api.crossref.org/works/10.1080%2F15622970902823202

21 January 2018

Oxcarbazepine in the treatment of bipolar and schizoaffective disorders

1 reference

https://api.crossref.org/works/10.1080%2F15622970902823202

21 January 2018

Ziprasidone in acute bipolar mania: a 21-day randomized, double-blind, placebo-controlled replication trial

1 reference

https://api.crossref.org/works/10.1080%2F15622970902823202

21 January 2018

Comparison of lithium carbonate and chlorpromazine in the treatment of mania. Report of the Veterans Administration and National Institute of Mental Health Collaborative Study Group

1 reference

https://api.crossref.org/works/10.1080%2F15622970902823202

21 January 2018

Reproductive function and risk for PCOS in women treated for bipolar disorder

1 reference

https://api.crossref.org/works/10.1080%2F15622970902823202

21 January 2018

Atypical antipsychotic drugs and the risk of sudden cardiac death

1 reference

https://api.crossref.org/works/10.1080%2F15622970902823202

21 January 2018

Prevalence of bipolar disorder in the general population: a Reappraisal Study of the Netherlands Mental Health Survey and Incidence Study.

1 reference

https://api.crossref.org/works/10.1080%2F15622970902823202

21 January 2018

Tardive dyskinesia: eliminated, forgotten, or overshadowed?

1 reference

https://api.crossref.org/works/10.1080%2F15622970902823202

21 January 2018

Australian and New Zealand clinical practice guidelines for the treatment of bipolar disorder

1 reference

https://api.crossref.org/works/10.1080%2F15622970902823202

21 January 2018

[Annual costs of bipolar disorders in Germany].

1 reference

https://api.crossref.org/works/10.1080%2F15622970902823202

21 January 2018

Quetiapine with lithium or divalproex for the treatment of bipolar mania: a randomized, double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1080%2F15622970902823202

21 January 2018

Aripiprazole in the treatment of acute manic or mixed episodes in patients with bipolar I disorder: a 3-week placebo-controlled study

1 reference

https://api.crossref.org/works/10.1080%2F15622970902823202

21 January 2018

Combination of a mood stabilizer with risperidone or haloperidol for treatment of acute mania: a double-blind, placebo-controlled comparison of efficacy and safety

1 reference

https://api.crossref.org/works/10.1080%2F15622970902823202

21 January 2018

Intramuscular aripiprazole : a review of its use in the management of agitation in schizophrenia and bipolar I disorder

1 reference

https://api.crossref.org/works/10.1080%2F15622970902823202

21 January 2018

Second-generation antipsychotic agents in the treatment of acute mania: a systematic review and meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1080%2F15622970902823202

21 January 2018

Bipolar Disorder in Neurologic Illness.

1 reference

https://api.crossref.org/works/10.1080%2F15622970902823202

21 January 2018

The prospective course of rapid-cycling bipolar disorder: findings from the STEP-BD.

1 reference

https://api.crossref.org/works/10.1080%2F15622970902823202

21 January 2018

The treatment of manic psychoses by the administration of lithium salts

1 reference

https://api.crossref.org/works/10.1080%2F15622970902823202

21 January 2018

Diagnosis and treatment of mixed mania.

1 reference

https://api.crossref.org/works/10.1080%2F15622970902823202

21 January 2018

Acute bipolar mania: a systematic review and meta-analysis of co-therapy vs. monotherapy.

1 reference

https://api.crossref.org/works/10.1080%2F15622970902823202

21 January 2018

Pharmacological interventions for acute bipolar mania: a systematic review of randomized placebo-controlled trials

1 reference

https://api.crossref.org/works/10.1080%2F15622970902823202

21 January 2018

Acute and continuation risperidone monotherapy in bipolar mania: a 3-week placebo-controlled trial followed by a 9-week double-blind trial of risperidone and haloperidol

1 reference

https://api.crossref.org/works/10.1080%2F15622970902823202

21 January 2018

Electroconvulsive therapy in treatment-resistant mania: case reports.

1 reference

https://api.crossref.org/works/10.1080%2F15622970902823202

21 January 2018

Clinically significant pharmacokinetic drug interactions with carbamazepine. An update

1 reference

https://api.crossref.org/works/10.1080%2F15622970902823202

21 January 2018

Magnitude of effect of lithium in short-term efficacy studies of moderate to severe manic episode

1 reference

https://api.crossref.org/works/10.1080%2F15622970902823202

21 January 2018

Tiagabine in treatment refractory bipolar disorder: a clinical case series.

1 reference

https://api.crossref.org/works/10.1080%2F15622970902823202

21 January 2018

Depression during mania. Treatment response to lithium or divalproex.

1 reference

https://api.crossref.org/works/10.1080%2F15622970902823202

21 January 2018

Pattern of response to divalproex, lithium, or placebo in four naturalistic subtypes of mania

1 reference

https://api.crossref.org/works/10.1080%2F15622970902823202

21 January 2018

Comparison of efficacy of lithium carbonate and chlorpromazine in mania. Report of collaborative study group on treatment of mania in Japan

1 reference

https://api.crossref.org/works/10.1080%2F15622970902823202

21 January 2018

Clinical trials in bipolar mania: implications in study design and drug development

1 reference

https://api.crossref.org/works/10.1080%2F15622970902823202

21 January 2018

Efficacy of olanzapine in acute bipolar mania: a double-blind, placebo-controlled study. The Olanzipine HGGW Study Group

1 reference

https://api.crossref.org/works/10.1080%2F15622970902823202

21 January 2018

A meta-analysis of the use of typical antipsychotic agents in bipolar disorder.

1 reference

https://api.crossref.org/works/10.1080%2F15622970902823202

21 January 2018

Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy

1 reference

https://api.crossref.org/works/10.1080%2F15622970902823202

21 January 2018

A 12-week, double-blind comparison of olanzapine vs haloperidol in the treatment of acute mania

1 reference

https://api.crossref.org/works/10.1080%2F15622970902823202

21 January 2018

Olanzapine versus divalproex sodium for the treatment of acute mania and maintenance of remission: a 47-week study

1 reference

https://api.crossref.org/works/10.1080%2F15622970902823202

21 January 2018

Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression

1 reference

https://api.crossref.org/works/10.1080%2F15622970902823202

21 January 2018

The McLean-Harvard First-Episode Mania Study: Prediction of Recovery and First Recurrence

1 reference

https://api.crossref.org/works/10.1080%2F15622970902823202

21 January 2018

Randomized, placebo-controlled trial of olanzapine as maintenance therapy in patients with bipolar I disorder responding to acute treatment with olanzapine

1 reference

https://api.crossref.org/works/10.1080%2F15622970902823202

21 January 2018

Olanzapine versus placebo in the treatment of adolescents with bipolar mania

1 reference

https://api.crossref.org/works/10.1080%2F15622970902823202

21 January 2018

Olanzapine plus carbamazepine v. carbamazepine alone in treating manic episodes

1 reference

https://api.crossref.org/works/10.1080%2F15622970902823202

21 January 2018

The treatment of mixed states and the risk of switching to depression

1 reference

https://api.crossref.org/works/10.1080%2F15622970902823202

21 January 2018

Role of risperidone in bipolar II: an open 6-month study.

1 reference

https://api.crossref.org/works/10.1080%2F15622970902823202

21 January 2018

Effectiveness of aripiprazole v. haloperidol in acute bipolar mania: double-blind, randomised, comparative 12-week trial

1 reference

https://api.crossref.org/works/10.1080%2F15622970902823202

21 January 2018

Olanzapine monotherapy and olanzapine combination therapy in the treatment of mania: 12-week results from the European Mania in Bipolar Longitudinal Evaluation of Medication (EMBLEM) observational study.

1 reference

https://api.crossref.org/works/10.1080%2F15622970902823202

21 January 2018

Ziprasidone for the treatment of acute manic or mixed episodes associated with bipolar disorder

1 reference

https://api.crossref.org/works/10.1080%2F15622970902823202

21 January 2018

Cross-national epidemiology of major depression and bipolar disorder

1 reference

https://api.crossref.org/works/10.1080%2F15622970902823202

21 January 2018

Drugs and Depression

1 reference

https://api.crossref.org/works/10.1080%2F15622970902823202

21 January 2018

Pharmacological treatment of acute mania in psychiatric in-patients between 1994 and 2004.

1 reference

https://api.crossref.org/works/10.1080%2F15622970902823202

21 January 2018

Mood stabilisers plus risperidone or placebo in the treatment of acute mania. International, double-blind, randomised controlled trial

1 reference

https://api.crossref.org/works/10.1080%2F15622970902823202

21 January 2018

Quetiapine versus placebo in combination with lithium or divalproex for the treatment of bipolar mania

1 reference

https://api.crossref.org/works/10.1080%2F15622970902823202

21 January 2018

Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: update 2007.

1 reference

https://api.crossref.org/works/10.1080%2F15622970902823202

21 January 2018

A double blind, randomized, placebo-controlled trial of quetiapine as an add-on therapy to lithium or divalproex for the treatment of bipolar mania

1 reference

https://api.crossref.org/works/10.1080%2F15622970902823202

21 January 2018

Protein kinase C inhibition in the treatment of mania: a double-blind, placebo-controlled trial of tamoxifen

1 reference

https://api.crossref.org/works/10.1080%2F15622970902823202

21 January 2018

Aripiprazole monotherapy in acute mania: 12-week randomised placebo- and haloperidol-controlled study

1 reference

https://api.crossref.org/works/10.1080%2F15622970902823202

21 January 2018

A rating scale for mania: reliability, validity and sensitivity

1 reference

https://api.crossref.org/works/10.1080%2F15622970902823202

21 January 2018

Double-blind comparison of the continued use of antipsychotic treatment versus its discontinuation in remitted manic patients

1 reference

https://api.crossref.org/works/10.1080%2F15622970902823202

21 January 2018

Efficacy of a protein kinase C inhibitor (tamoxifen) in the treatment of acute mania: a pilot study

1 reference

https://api.crossref.org/works/10.1080%2F15622970902823202

21 January 2018

An Exploratory Open Trial on Safety and Efficacy of the Anticonvulsant Retigabine in Acute Manic Patients

1 reference

https://api.crossref.org/works/10.1080%2F15622970902823202

21 January 2018

P.3.c.069 Day 4 partial response to ziprasidone predicts later treatment response in patients with bipolar disorder

1 reference

https://api.crossref.org/works/10.1080%2F15622970902823202

21 January 2018

Comparison of Rapid-Cycling and Non–Rapid-Cycling Bipolar I Manic Patients During Treatment With Olanzapine

1 reference

https://api.crossref.org/works/10.1080%2F15622970902823202

21 January 2018

Quetiapine dosage in bipolar disorder episodes and mixed states

1 reference

https://api.crossref.org/works/10.1080%2F15622970902823202

21 January 2018

Olanzapine compared to lithium in mania: a double-blind randomized controlled trial

1 reference

https://api.crossref.org/works/10.1080%2F15622970902823202

21 January 2018

Identifiers

10.1080/15622970902823202

1 reference

Europe PubMed Central

3 August 2017

1 reference

Europe PubMed Central

3 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34606256&oldid=1979601236"